MK-5478

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-5478, covering 2016-02-26 to 2016-02-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of MK-5478 in Participants With Hypertension (5478-001) [Phase 1]